|
Market Closed -
London S.E.
16:35:20 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.1200 GBX | 0.00% |
|
-7.69% | -44.19% |
| 08-27 | JPM Global Core liquidation; IGC shareholder's rebuke | AN |
| 08-27 | Oxford Biodynamics plc Announces Appointment of Richard Compton as Executive Director, Effective August 27, 2026 | CI |
| Market Cap | 6.01M 6.97M 5.65M 5.15M 9.68M 661M 9.75M 66.95M 26.02M 337M 26.15M 25.58M 1.12B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 10.91M 12.65M 10.27M 9.36M 17.58M 1.2B 17.7M 122M 47.25M 611M 47.48M 46.45M 2.03B | EV / Sales 2026 * |
5.83x | EV / Sales 2027 * | - |
| Free-Float |
94.62% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 week | -7.69% | ||
| 1 month | +9.09% | ||
| 3 months | -35.14% | ||
| 6 months | -53.85% | ||
| Current year | -44.19% |
| 1 week | 0.11 |  | 0.13 |
| 1 month | 0.1 | | 0.15 |
| Current year | 0.08 | | 0.34 |
| 1 year | 0.08 | | 0.75 |
| 3 years | 0.08 | | 52 |
| 5 years | 0.08 | | 53.6 |
| 10 years | 0.08 | | 278.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Compton
CEO | Chief Executive Officer | - | 29/06/2026 |
| Chief Tech/Sci/R&D Officer | 64 | 07/06/2007 | |
Paul Stockdale
DFI | Director of Finance/CFO | - | 14/09/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 07/06/2007 | |
Paul Stockdale
BRD | Director/Board Member | - | 14/09/2017 |
David Holbrook
BRD | Director/Board Member | 65 | 04/04/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/11/25 | Free | Founder | 15,000,000 | 0.7663% | ||
| 10/11/25 | Free | Executive/Senior Manager | 15,000,000 | 0.7663% | ||
| 10/11/25 | Free | Chief Operating Officer | 15,000,000 | 0.7663% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -7.69% | -74.74% | -98.92% | 6.98M | |
| +2.38% | +0.35% | -13.85% | -29.85% | 2.48B | |
| +1.43% | +17.65% | +17.20% | -82.37% | 2.22B | |
| +0.63% | -3.13% | -15.64% | -8.05% | 353M | |
| -0.22% | +2.23% | -44.55% | - | 53.61M | |
| Average | +0.84% | +1.79% | -26.32% | -54.80% | 1.02B | |
| Weighted average by Cap. | +1.82% | +5.93% | -0.89% | -51.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.87M 2.17M 1.76M 1.61M 3.02M 206M 3.04M 20.86M 8.11M 105M 8.15M 7.97M 348M | - |
| Net income | - | - |
| Net Debt | 4.9M 5.68M 4.61M 4.21M 7.9M 540M 7.95M 54.63M 21.23M 275M 21.34M 20.87M 911M | - |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | GBX 0.1200 | 0.00% | 2,665,486 |
| 28/08/26 | GBX 0.1200 | +2.56% | 21,540,567 |
| 27/08/26 | GBX 0.1170 | 0.00% | 11,495,458 |
| 26/08/26 | GBX 0.1170 | -4.10% | 159,729,348 |
| 25/08/26 | GBX 0.1220 | -6.15% | 938,302 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.001200GBP
Average target price
0.0100GBP
Spread / Average Target
+733.33%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OBD Stock
Select your edition
All financial news and data tailored to specific country editions
